Biomarkers for Early and Late Stage Chronic Allograft Nephropathy by Proteogenomic Profiling of Peripheral Blood

Abstract

BACKGROUND Despite significant improvements in life expectancy of kidney transplant patients due to advances in surgery and immunosuppression, Chronic Allograft Nephropathy (CAN) remains a daunting problem. A complex network of cellular mechanisms in both graft and peripheral immune compartments complicates the non-invasive diagnosis of CAN, which still… (More)
DOI: 10.1371/journal.pone.0006212

Topics

4 Figures and Tables

Cite this paper

@inproceedings{Kurian2009BiomarkersFE, title={Biomarkers for Early and Late Stage Chronic Allograft Nephropathy by Proteogenomic Profiling of Peripheral Blood}, author={Sunil M. Kurian and Raymond L. Heilman and Tony S Mondala and Aleksey A Nakorchevsky and Johannes A. Hewel and Daniel J. Campbell and Elizabeth H. Robison and Lin Wang and Wen Lin and Lillian W. Gaber and Kim Solez and Hamid Shidban and Robert Mendez and Randolph L. Schaffer and Jonathan S. Fisher and Stuart M. Flechner and Steve R. Head and Steve Horvath and John R. Yates and Christopher Lee Marsh and Daniel R. Salomon}, booktitle={PloS one}, year={2009} }